[1]
N. Mykhailovska, “The interrelation between cardiometabolic risk biomarkers and clinical features of chronic coronary syndrome in patients with non-alcoholic fatty liver disease”, RJDNMD, vol. 29, no. 2, pp. 173-182, Jun. 2022.